From foremost experts, this authoritative work offers a framework for helping children overcome obsessive–compulsive disorder (OCD) using the proven techniques of cognitive-behavioral therapy (CBT). Therapists gain knowledge and tools to engage 6- to 18-year-olds and their parents and implement individualized CBT interventions, with a focus on exposure and response prevention. In a user-friendly, conversational style, the authors provide real-world clinical guidance illustrated with vivid case examples. Purchasers get access to a Web page where they can download and print the volume's reproducible handouts in a convenient 8 1/2" x 11" size. Building on the earlier OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual (by John March and Karen Mulle), this book reflects two decades of advances in the field; most of the content is completely new.
Martin E. Franklin, PhD, is Associate Professor of Clinical Psychology in Psychiatry at the University of Pennsylvania School of Medicine, where he is also Director of the Child and Adolescent Obsessive–Compulsive Disorder (OCD), Tic, Trichotillomania, and Anxiety Group. Since the 1990s, Dr. Franklin has conducted research on psychopathology and treatment response in individuals with anxiety and related conditions across the developmental spectrum. He has lectured nationally and internationally on OCD, trichotillomania, Tourette syndrome, and related disorders. Dr. Franklin is also Clinical Director of Rogers Behavioral Health–Philadelphia, where he oversees partial hospitalization and intensive outpatient programs for anxiety/OCD and depression in youth.
Jennifer B. Freeman, PhD, is Director of Research and Training at the Pediatric Anxiety Research Center at Bradley Hospital and Associate Professor (Research) of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University. Her research focuses on child and adolescent anxiety disorders, with particular interests in obsessive–compulsive disorder, cognitive-behavioral family interventions, and developmental psychopathology. Dr. Freeman's current research focuses on dissemination of treatment and training programs for treatment providers in the area of exposure therapy.
John S. March, MD, MPH, is former Director of the Division of Neurosciences Medicine at the Duke Clinical Research Institute. He has extensive experience developing and testing treatments for pediatric mental disorders and has published widely on obsessive-compulsive disorder, posttraumatic stress disorder, anxiety, depression, attention-deficit/hyperactivity disorder, and pediatric psychopharmacology.
Martin E. Franklin, PhD, is Associate Professor of Clinical Psychology in Psychiatry at the University of Pennsylvania School of Medicine, where he is also Director of the Child and Adolescent Obsessive–Compulsive Disorder (OCD), Tic, Trichotillomania, and Anxiety Group. Since the 1990s, Dr. Franklin has conducted research on psychopathology and treatment response in individuals with anxiety and related conditions across the developmental spectrum. He has lectured nationally and internationally on OCD, trichotillomania, Tourette syndrome, and related disorders. Dr. Franklin is also Clinical Director of Rogers Behavioral Health–Philadelphia, where he oversees partial hospitalization and intensive outpatient programs for anxiety/OCD and depression in youth.
Jennifer B. Freeman, PhD, is Director of Research and Training at the Pediatric Anxiety Research Center at Bradley Hospital and Associate Professor (Research) of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University. Her research focuses on child and adolescent anxiety disorders, with particular interests in obsessive–compulsive disorder, cognitive-behavioral family interventions, and developmental psychopathology. Dr. Freeman's current research focuses on dissemination of treatment and training programs for treatment providers in the area of exposure therapy.
John S. March, MD, MPH, is former Director of the Division of Neurosciences Medicine at the Duke Clinical Research Institute. He has extensive experience developing and testing treatments for pediatric mental disorders and has published widely on obsessive-compulsive disorder, posttraumatic stress disorder, anxiety, depression, attention-deficit/hyperactivity disorder, and pediatric psychopharmacology.
